Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

The actual strategy to improve current therapies in advanced prostate cancer involves targeting genes activated by androgen withdrawal, either to delay or prevent the emergence of the castration-refractory phenotype. However, these genes are often implicated in several physiological processes, and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziouziou, Hajer, Andrieu, Claudia, Laurini, Erik, Karaki, Sara, Fermeglia, Maurizio, Oueslati, Ridha, Taieb, David, Camplo, Michel, Siri, Olivier, Pricl, Sabrina, Katsogiannou, Maria, Rocchi, Palma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652782/
https://www.ncbi.nlm.nih.gov/pubmed/29100389
http://dx.doi.org/10.18632/oncotarget.20469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652782/
https://www.ncbi.nlm.nih.gov/pubmed/29100389
http://dx.doi.org/10.18632/oncotarget.20469

Ejemplares similares